New policy changes from DOJ will impact False Claims Act cases moving forward.
In announcing a significant policy change, the U.S. Department of Justice (DOJ) said that when it concludes that a qui tam case lacks merit, it will file a motion to dismiss the case rather than allowing the relator to continue.
The surprise announcement was made by Michael Granston, director of the commercial litigation branch of the fraud section in the DOJ’s civil division, during the Health Care Compliance Association’s Health Care Enforcement Compliance Institute in Washington, D.C. on Monday.
Under the False Claims Act, when a relator or whistleblower files a qui tam action, the government has 60 days to determine whether it either takes over the litigation or declines to intervene in the case. Under the latter circumstances, the relator must determine whether to proceed using the relator’s own resources. (Note that courts nearly always extend that 60-day limit.)
While the federal government has always had the authority to dismiss a False Claims Act case, it has rarely done so. I am aware of two such cases, one in California and the other, in which I was involved, in Minnesota. Shortly after we celebrated the dismissal of the case, we learned that the DOJ had changed its position and would allow all cases to proceed if the relator was willing to do the work, even if the DOJ didn’t find the case meritorious.
During his presentation on Monday, Granston explained that the government recognizes that frivolous litigation creates a burden, not only for the government, but also for the courts and the healthcare industry. Therefore, when the DOJ concludes that a case is baseless going forward, it will file a motion to dismiss it.
The DOJ’s decision to file for a dismissal doesn’t guarantee the result; in theory, a judge could refuse to grant the motion and allow the case to proceed. However, from a practical perspective, such a result is unlikely. While it is impossible to predict how often the DOJ will seek dismissal of a case, the fact that the option exists is welcome news to the healthcare industry. Granston also provided some insight on the DOJ’s priorities over the next year. The government will be examining a variety of issues related to electronic health record (EHR) software, including whether the software documents information correctly and whether it properly qualifies for various incentive payments.
Diagnosis coding under Medicare Part C, often called the Medicare Advantage program, is also receiving scrutiny. Granston noted that the Part C program currently constitutes approximately one-third of all Medicare beneficiaries and accounts for approximately one-quarter of all Medicare spending. The government is concerned that some plans are reporting diagnoses that are not properly supported by the record, resulting in overpayments to the plan.
The government is also very interested in pursuing cases involving the delivery of substandard care, particularly in the skilled nursing facility (SNF) setting.
Finally, according to Granston, the government will be devoting considerable resources to resolving two open questions in the courts. In the Aseracare Hospice case, the judge concluded that if there is a dispute about medical necessity and an expert testifies that the care is necessary, the government cannot prevail in a False Claims Act case. The DOJ is deeply troubled by that result and hopes to reverse it on appeal. In addition, the courts have not yet definitively determined whether statistical sampling is allowed in a False Claims Act case. The government is hoping to convince the courts that sampling is appropriate.
The Centers for Medicare & Medicaid Services (CMS) sent a giant wave of panic through the industry this past week, when they announced that the
The U.S. Court of Appeals for the Sixth Circuit has handed the False Claims Act (FCA) bar another lesson in humility – and perhaps prompted
Please log in to your account to comment on this article.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
